MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Resequencing of the complete SNCA locus in Indian patients with Parkinson’s disease

    A. Kishore, M. Sturm, S. Krishnan, G. Sarma, C. Hakkaart, A. Sreelatha (Kochi, India)

    Objective: To perform targeted resequencing of the SNCA locus to identify novel variants in the Indian patients with Parkinsons’s disease (PD). Background: To date, most…
  • 2022 International Congress

    Statin use and incidence of Parkinson’s disease in women from the French E3N cohort study

    TTH. Nguyen, A. Fournier, E. Courtois, F. Artaud, S. Escolano, P. Tubert-Bitter, MC. Boutron-Ruault, I. Degaey, E. Roze, M. Canonico, I. Ahmed, ACM. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine whether incident statin use is associated with lower Parkinson’s disease (PD) incidence while considering the potential for reverse causation. Background: Drug repurposing…
  • 2022 International Congress

    Association between income and hospital length of stay in Parkinson Disease: a nationwide cross-sectional analysis

    P. Gros, D. Di Luca, C. Marras, A. Lang (Toronto, Canada)

    Objective: To investigate the relationship between income and hospital length of stay (LOS) and discharge disposition in a Parkinson Disease (PD) cohort admitted to the…
  • 2022 International Congress

    Time reproduction in Parkinson’s disease: Is there a specific impairment in context of movements?

    M. Ruppert, L. Torfah, V. Hammes, A. Greuel, F. Maier, L. Timmermann, D. Pedrosa Carrasco, C. Eggers (Marburg, Germany)

    Objective: Investigating the reproduction of time intervals in context of a motor imagery task in Parkinson’s disease Background: In Parkinson’s disease (PD), impaired perception of…
  • 2022 International Congress

    OPICAPONE ADD-ON THERAPY IN LEVODOPA-CARBIDOPA INTESTINAL GEL INFUSION: which patient might benefit the most?

    F. Colucci, V. Rispoli, V. Tugnoli, M. Pugliatti, G. Tecilla, M. Sensi (Ferrara, Italy)

    Objective: To explore the benefit of Opicapone (OPC) add-on to levodopa-carbidopa intestinal gel (LCIG) in different phenotypes of Parkinson’s Disease (PD) patients. Background: LCIG monotherapy…
  • 2022 International Congress

    Defining nomenclature and age cut off for Early Onset Parkinson’s Disease: Recommendations from the Early Onset Parkinson’s Disease Task Force.

    R. Mehanna, K. Smilowska, A. Merola, B. Zhang, B. Post, C. Marras, J. Fleisher, K. Kumar, M. Salari, O. Ross, R. Alcalay, T. Hatano, V. Mcconvey, Y-R. Wu, E-K. Tan, R. Savica (Houston, USA)

    Objective: To define the nomenclature for Early Onset Parkinson Disease (EOPD) / Young Onset Parkinson Disease (YOPD), and the age at onset (AAO) cut off…
  • 2022 International Congress

    A lower rate of hyposmia in non-Ashkenazi jewish patients with Parkinson’s disease: motor and non-motor disease characteristics in different ethnic groups in Israel

    ME. Cohen, E. Kohn, R. Valdman, R. Eichel, G. Yahalom (Jerusalem, Israel)

    Objective: We aim to describe clinical aspects of Parkinson's disease (PD) in different ethnic groups in Israel, focusing on Non-Ashkenzi Jews (NAJ) ethnic groups vs.…
  • 2022 International Congress

    Parkinson’s disease caregiver burden in rural India

    S. Desai, D. Desai, I. Prashnani (Anand, India)

    Objective: To assess the caregiver burden and factors determining it in patients with PD. To assess the anxiety and depression amongst caregivers. Background: Patients with…
  • 2022 International Congress

    PD+: A comprehensive, user-friendly mobile application for clinicians treating Parkinson’s Disease

    E. Shah, T. Khachatryan, N. Phielipp, S. Isfahani (Orange, USA)

    Objective: We developed a mobile application that converts dopaminergic medication dosages and calculates total Levodopa (L-dopa) equivalent daily dose (LEDD) in a Parkinson’s Disease (PD)…
  • 2022 International Congress

    The mitochondrial risk score and lifestyle factors are associated with age at onset in LRRK2 p.Gly2019Ser Parkinson’s disease.

    T. Lüth, C. Gabbert, P. Lajer, I. König, A. Caliebe, S. Koch, B-H. Laabs, F. Hentati, S. Sassi, R. Amouri, C. Klein, A. Grünewald, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To investigate the relationship between a mitochondrial risk score (MRS), lifestyle and age at onset (AAO) in LRRK2 G2019S Parkinson’s disease (PD). Background: PD…
  • « Previous Page
  • 1
  • …
  • 290
  • 291
  • 292
  • 293
  • 294
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley